Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection-Reference-Cited by-同舟云学术

Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection

Published:2013-07 Issue:1 Volume:1291 Page:69-76
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Hazuda Daria J.¹,Burroughs Margaret²,Howe Anita Y.M.³,Wahl Janice³,Venkatraman Srikanth³

Affiliation:

1. Merck Research Laboratories; West Point Pennsylvania

2. Merck Research Laboratories; Rahway New Jersey

3. Merck Research Laboratories; Kenilworth New Jersey

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.12218/fullpdf

Reference31 articles.

1. Chronic hepatitis C: an age wave of disease burden;McHutchison;Am. J. Manag. Care,2005

2. The way forward in HCV treatment-finding the right path;Manns;Nat. Rev. Drug Discovery,2007

3. Centers for Disease Control and Prevention Division of Viral Hepatitis and National Center for HIV/AIDS. 2012. Viral Hepatitis, STD, and TB Prevention 2012 http://www.cdc.gov/hepatitis/c/cfaq.htm

4. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients;Susser;Hepatology,2009

5. Development of novel treatments for hepatitis C;Webster;Lancet Infect. Dis,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M ^pro /3CL ^pro in Living Cells;mBio;2022-06-28

2. Molecules Containing Cyclobutyl Fragments as Therapeutic Tools: A Review on Cyclobutyl Drugs;Current Medicinal Chemistry;2022-06-10

3. HCV Virology;Hepatitis C: Epidemiology, Prevention and Elimination;2021

4. Gain-of-function assay for SARS-CoV-2 Mpro inhibition in living cells;2020-11-09

5. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data;Infectious Diseases and Therapy;2019-02-15